Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
52.2M
-
Shares change
-
+1.22M
-
Total reported value, excl. options
-
$1.1B
-
Value change
-
+$23.3M
-
Number of buys
-
72
-
Number of sells
-
-32
-
Price
-
$20.99
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q2 2020
130 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q2 2020.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.2M shares
.
Largest 10 shareholders include FMR LLC (9.41M shares), BAUPOST GROUP LLC/MA (9.31M shares), VANGUARD GROUP INC (4.7M shares), WELLINGTON MANAGEMENT GROUP LLP (4.48M shares), BlackRock Inc. (4.38M shares), ORBIMED ADVISORS LLC (2.55M shares), AMERIPRISE FINANCIAL INC (1.5M shares), NORGES BANK (1.26M shares), JANE STREET GROUP, LLC (1.22M shares), and STATE STREET CORP (1.11M shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.